BQ 3020
£125.00 1mg
Please note: this product can only be supplied to registered research and development facilities, and may be used for in vitro research use only, not for administration to humans or animals.
Selective ETB receptor agonist.
BQ 3020 is a linear analogue of endothelin-1 (ET-1) which is a highly potent and selective ETB endothelin receptor agonist with Ki values of 0.18 and 970 nM at human ETB and ETA receptors. Intratumour administration of BQ 3020 can attenuate cancer pain by modulating ?-endorphin release from squamous cell carcinoma cells in mouse models.
Please contact us for availability.
Additional information
| Three Letter Sequence | Ac-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp-OH |
|---|---|
| Molecular Weight | 2006.35 |
| Molecular Formula | C96H140N20O25S |
| Sequence | Ac-LMDKEAVYFAHLDIIW |
| Solubility | Soluble to 0.50 mg/ml in sodium bicarbonate (0.03M) |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| Purity | >95% by HPLC |
| Modifications | N terminal acetyl |
| Searchable Words | BQ-3020, BQ3020, 143113-45-5, Ac-LMDKEAVYFAHLDIIW, LMDKEAVYFAHLDIIW |